Libre von Abbott - DE
Libre von Abbott is a continuous glucose monitoring companion app for Android and iOS that provides real-time sensor data and clinical sharing tools.
The App DNA
What makes this app unique?
Users report: The app removes the friction of manual glucose logging by automating data capture and integrating it into the clinical management workflow of healthcare providers.
For Individuals diagnosed with diabetes requiring continuous glucose monitoring and their designated caregivers or healthcare providers.
What does it look like?
Key features
Automatic glucose readings updated every minute on the smartphone display.
Generative AI feature that predicts glucose impact based on user-provided meal photos.
Configurable glucose threshold notifications with adjustable volume and mute periods.
Cloud-based data sharing for glucose history with healthcare providers and caregivers.
How much does it cost?
The app functions as a free companion tool for proprietary hardware sensors, with monetization tied to physical product sales.
Velocity
Maintenance developmentperformanceopaqueShow more...
With two releases over the last 68 days, the app maintains a maintenance-level cadence of approximately 0.15 releases per week. Development is currently focused exclusively on stability and security, as the latest release provided only generic security updates and the prior version lacked descriptive notes. There is no evidence of new feature development or live operations, indicating a stable, low-frequency update cycle.
Who built it?
Abbott Diabetes Care
13+ apps tracked · Medical
User Sentiment
What do users think recently?
Fresh user feedback skews mixed.
How are ratings & reviews evolving?
What users say, by theme
- Signal loss alarm fails to trigger despite users adjusting every available setting in the menu
2 of 2 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Libre von Abbott - DE
How's the Medical market?
Libre von Abbott holds the #6 position in the Medical category (DE), reflecting its role as a utility-focused companion for proprietary hardware. The lack of IAP monetization signals that its primary function is to secure the sensor-subscription funnel rather than generate direct app revenue.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Libre von Abbott - DE
Where is it heading?
The market for CGM companion apps is shifting toward deeper clinical integration and AI-driven insights, areas where Libre von Abbott is well-positioned. However, the current failure to maintain basic utility features like alarms and widgets creates a vulnerability that could lead users to seek more reliable, albeit less integrated, alternatives.
- Persistent alarm failures and widget regressions in the latest release degrade core utility, which directly threatens long-term sensor subscription retention.
- The current maintenance-only release cadence suggests a focus on stability, yet the recent regressions indicate that current quality assurance processes are insufficient.
The SWOT
- Proprietary hardware integration creates high switching costs
- Cloud-based provider connectivity embeds app into clinical workflows
- AI-driven meal insights could include automated carb-counting
Next best moves
Rebuild alarm notification logic because signal loss alerts are failing → restore core safety utility
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of direct monetization is its greatest strength…
Read the full takeBottom line
Libre von Abbott maintains its position through hardware lock-in, but the persistence of core utility failures (alarm and widget regressions) risks alienating the daily active user base. Addressing these stability issues is the necessary move to protect the sensor-subscription funnel.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing
Report last updated